hamid zarabi - Academia.edu (original) (raw)
Uploads
Papers by hamid zarabi
Practice in Clinical Psychology, 2022
Objective: Somatic Symptom Disorder (SSD) is characterized by somatic symptoms that are very dist... more Objective: Somatic Symptom Disorder (SSD) is characterized by somatic symptoms that are very distressing or cause considerable functional disability. SSD is associated with various medical and psychiatric conditions and imposes high costs on the health care system. Therefore, early diagnosis and treatment of SSD are crucial. The somatic symptom scale-8 (SSS-8) is a valuable and brief self-report questionnaire to assess somatic symptom burden. The current study determined the psychometric properties of the Persian version of SSS-8 in depressed samples. Methods: The study data were collected from a clinical setting with individuals diagnosed with major depressive disorder (MDD, n=122). The convergent validity of SSS-8 was examined by assessing its correlation with the hospital anxiety and depression scale (HADS), the Whiteley index (WI-14), and somatic symptom disorder-B criteria scale (SSD-12) questionnaires. Results: The Cronbach α results confirmed the reliability of SSS-8. Reliabi...
Neurocase, 2022
To evaluate the evidences related to the effectiveness of neurofeedback treatment for children an... more To evaluate the evidences related to the effectiveness of neurofeedback treatment for children and adolescent with attention-deficit/hyperactivity disorder (ADHD) based on the most-proximal raters. A systematic review of randomized control trials (RCTs) was carried out across multiple databases. the primary outcome measure was the most proximal ratings of ADHD symptoms in subjects. Conner's Parent Rating Scale (CPRS), Conner's Teacher Rating Scale (CTRS), and ADHD Rating Scale (ADHD-RS- are considered as primary outcomes. Seventeen trials met inclusion criteria (including 1211 patients). Analysis showed that there was no significant benefit of neurofeedback treatment compared with other treatments or control conditions [weighted mean difference/CI = HI-P: -0.02 (-0.26, 0.21), HI-T: 0.01 (-0.46, 0.48), weighted mean difference/CI = I-P: 0.00 (-0.23, 0.23), I-P: 0.12 (-0.14, 0.38)]. The results provide preliminary evidence that neurofeedback treatment is no efficacious clinical method for ADHD and suggest that more RTCs are needed to compare common treatment .
Practice in Clinical Psychology, 2022
Objective: Somatic Symptom Disorder (SSD) is characterized by somatic symptoms that are very dist... more Objective: Somatic Symptom Disorder (SSD) is characterized by somatic symptoms that are very distressing or cause considerable functional disability. SSD is associated with various medical and psychiatric conditions and imposes high costs on the health care system. Therefore, early diagnosis and treatment of SSD are crucial. The somatic symptom scale-8 (SSS-8) is a valuable and brief self-report questionnaire to assess somatic symptom burden. The current study determined the psychometric properties of the Persian version of SSS-8 in depressed samples. Methods: The study data were collected from a clinical setting with individuals diagnosed with major depressive disorder (MDD, n=122). The convergent validity of SSS-8 was examined by assessing its correlation with the hospital anxiety and depression scale (HADS), the Whiteley index (WI-14), and somatic symptom disorder-B criteria scale (SSD-12) questionnaires. Results: The Cronbach α results confirmed the reliability of SSS-8. Reliabi...
Neurocase, 2022
To evaluate the evidences related to the effectiveness of neurofeedback treatment for children an... more To evaluate the evidences related to the effectiveness of neurofeedback treatment for children and adolescent with attention-deficit/hyperactivity disorder (ADHD) based on the most-proximal raters. A systematic review of randomized control trials (RCTs) was carried out across multiple databases. the primary outcome measure was the most proximal ratings of ADHD symptoms in subjects. Conner's Parent Rating Scale (CPRS), Conner's Teacher Rating Scale (CTRS), and ADHD Rating Scale (ADHD-RS- are considered as primary outcomes. Seventeen trials met inclusion criteria (including 1211 patients). Analysis showed that there was no significant benefit of neurofeedback treatment compared with other treatments or control conditions [weighted mean difference/CI = HI-P: -0.02 (-0.26, 0.21), HI-T: 0.01 (-0.46, 0.48), weighted mean difference/CI = I-P: 0.00 (-0.23, 0.23), I-P: 0.12 (-0.14, 0.38)]. The results provide preliminary evidence that neurofeedback treatment is no efficacious clinical method for ADHD and suggest that more RTCs are needed to compare common treatment .